PCM
SLXP

Portolan Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Portolan Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,026
Closed -$336K – 155
2013
Q3 		$336K Hold
5,026
– – 0.09% 114
2013
Q2 		$332K Buy
+5,026
New +$332K 0.09% 139